Jazz Pharmaceuticals director Bruce C. Cozadd reports sale of $16.24 million in common shares
JAZZ•Director Bruce C. Cozadd sold 68,808 ordinary shares on Nov. 6, 2026, and exercised options to acquire 86,500 shares at $136.18 each. He directly owned 357,567 ordinary shares after the transactions, according to a Nov. 10 filing.
1. Share transactions
Bruce C. Cozadd sold 68,808 Jazz Pharmaceuticals ordinary shares on Nov. 6, 2026. The same day, he exercised stock options to acquire 86,500 ordinary shares at $136.18 per share. Following the transactions, he directly owned 357,567 ordinary shares, according to a Nov. 10 filing.
